20
Ctx Life Sciences Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OXYMETAZOLINE HYDROCHLORIDE USP, with a corresponding US DMF Number 22401.
Remarkably, this DMF maintains an Active status since its submission on December 10, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 18, 2015, and payment made on January 04, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II